Kyrsten Sinema's Psychedelic Advocacy and Trump Administration Ties

Sinema's Psychedelic Advocacy

• 💡 Former Senator Kyrsten Sinema is now advocating for psychedelic medicine, specifically ibogaine, derived from an African shrub.
• 🎯 She aims to have ibogaine studied in state-funded clinical trials and eventually gain FDA approval as a mental health treatment.
• 🧠 Sinema describes her personal experience with ibogaine as a 15-hour ordeal with a "machine clunking around" in her head, but claims it left her brain feeling "crystal clear" and "snappy."
• 💰 She states her advocacy is pro bono, meaning she is not financially benefiting from it.

Political Connections and Funding

• 🤝 Sinema is aligning with Robert F. Kennedy Jr., who also supports psychedelic medicine, and sees opportunity within the Trump administration.
• 📈 She has had recent success at the state level, lobbying Arizona Governor Katie Hobbs to include $5 million in ibogaine research funding in the state budget.
• 💰 Texas Governor Greg Abbott also signed a bill securing $50 million in state funding for ibogaine research.

Criticisms and Concerns

• ⚠️ Experts express concerns about ibogaine, noting that robust research has not been done on its effects and it poses heart risks.
• 🚫 The DEA lists ibogaine as a drug with no acceptable medical use and a high risk of abuse.
• 🧐 Critics question the timing of this advocacy, especially in light of potential cuts to other medical research funding, like cancer research.
• 🤨 There is skepticism about Sinema's motives, with suggestions that she is pursuing a "grifting career" and trying to make more money after leaving the Senate.